解读乳腺癌:新兴的分子生物标记物和精准医学的新疗法标
Dámaris P Intriago-Baldeón1, Eduarda Sofía Pérez-Coral1, Martina Isabella Armas Samaniego2
1Grupo de Investigación en Biomedicina Experimental y Aplicada, Facultad de Ciencias de la Salud, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador.
International journal of molecular sciences
|January 10, 2026
概括
本综述涵盖了乳腺癌的经典和新兴生物标志物,包括雌激素/孕受体,HER2,Ki-67,TP53和EGFR. 了解这些生物标志物有助于精准医学,并提高治疗成功.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌是全球癌症死亡的主要原因,其特点是显著的分子异质性.
- 这种异质性使临床管理和治疗反应预测复杂化.
- 目前的分子分类反映了瘤亚型内的独特的遗传变化和信号通路.
研究的目的:
- 审查乳腺癌中的经典和新兴生物标志物.
- 讨论相关疗法及其临床影响.
- 突出生物标志物在推进精准医学中的作用.
主要方法:
- 经典和新兴乳腺癌生物标志物的文献综述.
- 对已确定的标记物的分析,如雌激素和孕激素受体,HER2和Ki-67.
- 识别和讨论新的生物标记物,包括TP53,EGFR,RNA和表观遗传/免疫学标记物.
主要成果:
- 经典的生物标志物 (ER,PR,HER2,Ki-67) 在充分表征乳腺癌方面存在局限性.
- 新兴的生物标志物如TP53,EGFR,各种RNA和表观遗传/免疫学标志物提供了更深入的见解.
- 这些生物标志物的整合增强了对分子复杂性的理解.
结论:
- 新的生物标志物补充了传统的生物标志物,改善了乳腺癌亚型的特征.
- 精准医学策略,以全面的生物标志物分析为基础,提高治疗成功率.
- 对生物标志物的持续研究对于个性化乳腺癌治疗至关重要.
更多相关视频
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
16.1K
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.8K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K